Bringing new therapies to market is a complex task, involving a myriad teams starting at initial R&D, through clinical trials and regulatory approval, all the way to commercial manufacturing.

The ability to accurately, effectively and—above all—securely communicate key data among many teams, partners, vendors and regulators, all while complying with GxP requirements, is essential to the process.